The DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index.
Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management
Abstract
Although first described about 100yr ago, atrial fibrillation (AF) is now recognized as the most common of all arrhythmias. It has a substantial morbidity and presents a considerable health care burden. Improved diagnosis and an ageing population with an increased likelihood of underlying cardiac disease results in AF in more than 1% of population. AF is associated with an approximately two-fold increase in mortality, largely due to stroke which occurs at an annual rate of 5-7%. Another risk to survival is heart failure, which is aggravated by poor control of the ventricular rate during AF. Usually AF is associated with a variety of symptoms: palpitations, dyspnea, chest discomfort, fatigue, dizziness, and syncope. Paroxysmal AF is likely to be symptomatic and frequently presents with specific symptoms, while permanent AF is usually associated with less specific symptoms. However, in at least one third of patients, no obvious symptoms or noticeable degradation of quality of life are observed. This asymptomatic, or silent, AF is diagnosed incidentally during routine physical examinations, pre-operative assessments or population surveys. Recently, a very large incidence of generally short paroxysms of AF has been seen in patients with implantable pacemakers or defibrillators and these arrhythmias are often silent. Pharmacological suppression of arrhythmia may be associated with a conversion from a symptomatic to an asymptomatic form of AF. Holter monitoring and transtelephonic monitoring studies have demonstrated that asymptomatic episodes of AF exceed symptomatic paroxysms by twelve-fold or more. Although symptoms may not stem directly from AF, the risk of complications is probably the same for symptomatic and asymptomatic patients. AF is found incidentally in about 25% of admissions for a stroke. Studies in patients with little or no awareness of their arrhythmia condition indicate that unrecognized and untreated AF may cause congestive heart failure. In patients with coronary bypass, AF may not only represent risk for immediate postoperative morbidity and increase hospital resource utilization, but being unrecognized, may produce a significant impact on long-term survival and quality of life. Although silent AF merits consideration for anticoagulation and rate control therapy according to standard criteria, whether antiarrhythmic therapy is relevant in this condition remains unclear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Silent, undetected AF is common, 120,122 with severe consequences such as stroke and death.[123][124][125]”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [122]
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Epidemiologic Features of Chronic Atrial Fibrillation
Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204293061703 · Cited by 2,304
Krahn, A. D., Manfreda, J., TATE, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80348-9 · Cited by 1,478
Incidence of and risk factors for atrial fibrillation in older adults
Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., White, R., Furberg, C. D., & Rautaharju, P. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2455 · Cited by 1,462
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
The Natural History of Lone Atrial Fibrillation
Kopecky, S. L., Gersh, B. J., McGoon, M. D., Whisnant, J. P., Holmes, D. R., Ilstrup, D. M., & Frye, R. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171104 · Cited by 936
Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study
Ott, A., Breteler, M. M. B., de Bruyne, M. C., van Harskamp, F., Grobbee, D. E., & Hofman, A. (1997) · Stroke · doi:10.1161/01.str.28.2.316 · Cited by 732
Page, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.1.224 · Cited by 627 · cited 1×
“6% of calls which were not associated with symptoms [25].”
Background
Flagged first, then by citations
2 of the 76 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- Garrigue S, Cazeau S, Ritter P, Lazarus A, Gras D, Mugica J. [Incidence of atrial arrhythmias in patients with dual-chamber pacemakers: value of the pacemaker Holter function] [French]. Arch Mal Coeur Vas 1996;89:873-881.
- Lombardi F, Tozillo D, Cappiello E. Sympatho-vagal influence in atrial fibrillation. N Trends Arrhythmias 1993;9:179-184.
- Feinberg WM, Seeger JF, Carmody RF, Anderson DC, Hart RG, Pearce LA. Asymptomatic cerebral infarction in patients with atrial fibrillation. Circulation 1988;19:955-957.
- Kulbertus HE, de Leval-Rutten F, Bartsch P, Petit JM. Atrial fibrillation in elderly, anbulatory patients. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial fibrillation. Mölndal: AB Hässle, 1982:148-157.
- Howes CJ, Brandt C, Yerkey MW, Ruo B, Reid C, Ezekowitz MD. Quality of life and exercise tolerance in elderly, ambulatory patients with chronic atrial fibrillation. Circulation 1998;98(Suppl):I-703-I-704 (abstr).
- Paquette M, Roy D, Talajic M, Newman D, Dorian P, for the CTAF Investigators. Sinus rhythm at the time of assessment is associated with better quality of life than atrial fibrillation or flutter results from the Canadian Trial of Atrial Fibrillation. PACE 1999;22: 863(abstr).
Cited by
Sorted by citations
Items 301–340 of 340
Pürerfellner, H. (2004) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Highlighting patient eligibility for elective DC cardioversion: ‘Jump Start’ a software solution
Lapper, A., Caines, P., Puri, P., Shoker, B., & Smallwood, A. (2010) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2010.5.10.78867
ASymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial
Connolly, S. J., Hohnloser, S. H., Morillo, C. A., Healey, J. S., Israel, C. W., Lade, K., Gold, M. R., Fain, E. S., & Capucci, A. (2004)
Follow‐up after ablation: assessing success, symptom status, and recurrent arrhythmias
Kircher, S., Eitel, C., & Hindricks, G. (2015) · Wiley eBooks · doi:10.1002/9781118658369.ch24
TIA oder Aura — wie sicher ist die Diagnose?
Franz, P. (2012) · NeuroTransmitter · doi:10.1007/s15016-012-0515-7
Diagnostic Aspects of Implantable Devices
Ziegler, P., Hettrick, D. A., Padeletti, L., & Saksena, S. V. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00091-0
Pacing Technology and Its Indications
Lau, C., & Siu, C.-W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00033-8
Myocardial electrical impedance as a metric of completeness for radiofrequency ablation lesions
Dumas, J. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/63p7-0x47
Screening for atrial fibrillation in high-risk individuals : a stroke preventive effort
Svennberg, E. (2016) · Figshare
Stroke and the heart : a focus on atrial fibrillation and heart failure
Abdul‐Rahim, A. H. (2017) · Enlighten: Theses (The University of Glasgow)
Detection and Predictors of Atrial Fibrillations in patients after pacemaker implantations.
Chudzik, M., & Nowek, A. (2017) · Heart Beat Journal · doi:10.24255/hbj/68145
OBSOLETE: Pharmacogenomics of Antiarrhythmic Drug Therapy for Atrial Fibrillation
Darbar, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99763-0
Antiarrhythmic Drug Management of Atrial Fibrillation
Camm, A. J., & Savelieva, I. (2017) · Cardiovascular medicine · doi:10.1007/978-3-319-58000-5_8
Self-citationMusa, A. F., Dillon, J., Taib, M. E. M., Yunus, A. M., Nordin, R. B., & Hay, Y. K. (2018) · F1000Research · doi:10.12688/f1000research.12912.1
Screening, optimization, support: a call for stroke prevention in atrial fibrillation
Induruwa, I., Liu, W., & Khadjooi, K. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.8.424
Atrial Fibrillation a Benign Condition? Quality of Life Approach
Ţică, O., Țica, O., Hatos, A., Pantea-Roșan, L. R., & Popescu, M. I. (2018) · Central European Journal of Clinical Research · doi:10.2478/cejcr-2018-0008
Kumar, S., & Michaud, G. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00076-6
Barmano, N. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-156364
Allan, V., Sammon, C., McDonald, L., Mehmud, F., Alikhan, R., & Ramagopalan, S. V. (2019) · Future Cardiology · doi:10.2217/fca-2019-0025
Identification of Atrial Fibrillation in Secondary Care Diabetes and Vascular Clinics: A Pilot Study
Kalia, K., Tulloh, R. M. R., & Grubb, N. R. (2020) · Future Cardiology · doi:10.2217/fca-2019-0010
Hammer, A., Schnaubelt, S., Niessner, A., & Sulzgruber, P. (2020) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaa176
Active Supraventricular Arrhythmias
Bayés‐Genís, A., Fiol, M., Bayés‐Genís, A., Baranchuk, A. M., Elosúa, R., & Martínez‐Sellés, M. (2021) · doi:10.1002/9781119536475.ch15
Active Supraventricular Arrhythmias
de Luna, A. B., & FCCS, A. B. M. F. F. (2017) · Wiley eBooks · doi:10.1002/9781119212782.ch4
Prevention of Atrial Fibrillation
Kornej, J., & Benjamin, E. J. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_23
Detection of atrial fibrillation
Gurp, N. V.-V. (2022) · doi:10.26481/dis.20220325nv
Atrial fibrillation – all change!
Leatham, A., Savelieva, I., & Camm, A. J. (2007) · Clinical Medicine · doi:10.7861/clinmedicine.7-5-526
Self-citationPharmacogenomics of Antiarrhythmic Drug Therapy for Atrial Fibrillation
Darbar, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99763-1
Active Supraventricular Arrhythmias
de Luna, A. B. (2012) · doi:10.1002/9781118392041.ch15
Rodriguez, P. R. T., Fayyaz, F., Deiveegan, D. S., Arif, D. A., Bukhari, H., Mulaka, G. S. R., Doddareddy, N. P., Ekomwereren, O., Atew, H. G., Mukherjee, S., et al. (2023) · International Journal of Pharmacy and Pharmaceutical Research · doi:10.25166/ijppr.2023.28.2.8
Pharmacogenomics of Antiarrhythmic Drug Therapy for Atrial Fibrillation
Barney, M., & Darbar, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00018-2
Screening of Diabetic and Heart Failure Patients for Silent Atrial Fibrillation
Silajdzija, E., Lund, I. M., Jensen, J. B., Sheikh, A. P., Hansen, J. L., Tourkaman, M., Heinesen, V., Kallemose, T., Lillqvist, J., Steinwender, C., et al. (2024) · CJC Open · doi:10.1016/j.cjco.2024.11.023
Coumel, P. (2002) · Springer eBooks · doi:10.1007/978-88-470-2103-7_56
Gabet, A. (2020) · theses.fr (ABES) · doi:10.70675/9198c42dz4c35z433azbc57z01140d9f75af
Lôbo, A. D. O. M., Kelly, F. A., Pardo, I., & d’Ávila, A. (2026) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-026-02366-y
Okamura, S., Furutani, M., Nakashima, M., Oda, N., Tokuyama, T., Okubo, Y., Miyauchi, S., Miyamoto, S., Oguri, N., Sakai, T., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.07.022
RESULTS OF THE REGIONAL PROJECT “KUZBASS WITHOUT ARRHYTHMIA”
Захирович, Х. З., Mamchur, S. E., Gorbunova, E. V., Altymysheva, A. N., Александровна, А. Т., & Kleshcheva, A. V. (2026) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2026-15-1-174-179
Mędrek, S., Zaborowska-Szmit, M., & Szmit, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1853400
Jackson, A., Fröbert, O., Larsen, D. B., Giordano, R., Arendt‐Nielsen, L., & Björkenheim, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-78180-3
Klassifikationen, Erkrankungsverläufe und Symptomatologie
CARLSSON, J., NEUZNER, J., & Erdogan, A. R. (2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1748-6_3
Metadata
- Authors
- Savelieva, I., & Camm, A. J.
- Affiliations
- St George's, University of London (GB)
- Venue
- Journal of Interventional Cardiac Electrophysiology
- Published
- 2000-06
- Volume
- 4
- Issue
- 2
- Pages
- 369-382
- ISSN
- 1383-875X (ISSN-L)
- 1572-8595
- OpenAlex
- W107386444
- Cited by
- 339
- References
- 76
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 11 · 2023: 8 · 2022: 14 · 2021: 9 · 2020: 18 · 2019: 20 · 2018: 24 · 2017: 21 · 2016: 23 · 2015: 21 · 2014: 18 · 2013: 12 · 2012: 19
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Interventional Cardiac Electrophysiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Keywords
- silent atrial fibrillation, asymptomatic atrial fibrillation, atrial fibrillation prevalence, atrial fibrillation prognosis, quality of life, stroke risk, heart failure, ventricular rate control, antiarrhythmic therapy, anticoagulation, cardiac implantable electronic devices, Holter monitoring, transtelephonic monitoring, coronary artery bypass grafting, mortality
- MeSH terms
- Atrial Fibrillation, Humans, Prognosis, Quality of Life, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review